← All companies
I
ImmunityBio, Inc.
IBRX - Company ID 0001326110
Market cap$9.29 B
Rank#1001
Filings528
ImmunityBio, Inc. has filed 528 public company documents between 2005 and 2026. The most frequent type is insider trade (204 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Continue researchIBRX overview$9.29 BMarket cap, financials, charts, and latest company context.
Continue researchMarket cap historyRank #1001See the market value trend behind the filing history.
Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.
Continue researchCompare with AMGNPeer viewPut IBRX beside AMGN across market cap, revenue, income, and filings.
Similar companies to research next
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.